PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System

被引：11
|
作者：
Shu, Linjing [1 ,2 ]
Huang, Renhuan [1 ]
Wu, Songtao [1 ]
Chen, Zhaozhao [1 ]
Sun, Ke [1 ]
Jiang, Yan [1 ]
Cai, Xiaoxiao [1 ]
机构：
[1] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, 14,3rd Sec,Ren Min Nan Rd, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, West China Hosp Stomatol, Dept Oral Implantol Ctr, Chengdu 610041, Sichuan Provinc, Peoples R China
来源：
CURRENT STEM CELL RESEARCH & THERAPY | 2016年 / 11卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Antitumor; chemoprevention; digestive system; peroxisome proliferator-activated receptor gamma; thiazolidinediones (TZDs); tumor cells; ACTIVATED-RECEPTOR-GAMMA; INHIBITS CELL-GROWTH; PANCREATIC-CANCER CELLS; MOUSE COLON CARCINOGENESIS; CARCINOMA IN-VITRO; GASTRIC-CANCER; COLORECTAL-CANCER; LINOLEIC-ACID; PERITONEAL METASTASIS; INDUCED APOPTOSIS;
D O I：
10.2174/1574888X10666150630111618
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a versatile member of the ligand-activated nuclear hormone receptor superfamily of transcription factors, with expression in several different cell lines, especially in the digestive system. After being activated by its ligand, PPAR gamma can suppress the growth of oral, esophageal, gastric, colorectal, liver, biliary, and pancreatic tumor cells, suggesting that PPAR gamma ligand is a potential anticancer agent in PPAR gamma-expressing tumors. This review highlights key advances in understanding the effects of PPAR gamma ligands in the treatment of tumors in the digestive system.
引用
收藏
页码：274 / 281
页数：8
相关论文
共 50 条
  • [1] PPAR ligands: Are they potential agents for cardiovascular disorders?
    Balakumar, Pitchai
    Rose, Madhankumar
    Singh, Manjeet
    PHARMACOLOGY, 2007, 80 (01) : 1 - 10
  • [2] PPARα Ligands as Antitumorigenic and Antiangiogenic Agents
    Pozzi, Ambra
    Capdevila, Jorge H.
    PPAR RESEARCH, 2008, 2008
  • [3] Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents
    Zhao, Ting-Ting
    Xu, Yu-Qing
    Hu, Hui-Min
    Gong, Hai-Bin
    Zhu, Hai-Liang
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (37) : 6786 - 6796
  • [4] Betulinic Acid and its Derivatives as Potential Antitumor Agents
    Zhang, Dong-Mei
    Xu, Hong-Gui
    Wang, Lei
    Li, Ying-Jie
    Sun, Ping-Hua
    Wu, Xiao-Ming
    Wang, Guang-Ji
    Chen, Wei-Min
    Ye, Wen-Cai
    MEDICINAL RESEARCH REVIEWS, 2015, 35 (06) : 1127 - 1155
  • [5] FLUORASQUIN AND ITS DIETHYL ESTER - NEW POTENTIAL ANTITUMOR AGENTS
    HYNES, JB
    GARRETT, CM
    BUCK, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1975, (169): : 13 - 13
  • [6] PPAR-α Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration
    Cano, Marisol del V.
    Gehlbach, Peter L.
    PPAR RESEARCH, 2008, 2008
  • [7] Synthesis of 3′-β-carbamoylmethylcytidine (CAMC) and its derivatives as potential antitumor agents
    Ichikawa, S
    Minakawa, N
    Shuto, S
    Tanaka, M
    Sasaki, T
    Matsuda, A
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (07) : 1284 - 1296
  • [8] PPAR ligands: Potential therapies for metabolic syndrome
    Akiyama T.E.
    Meinke P.T.
    Berger J.P.
    Current Diabetes Reports, 2005, 5 (1) : 45 - 52
  • [9] Potential Therapeutic Effects of PPAR Ligands in Glioblastoma
    Basilotta, Rossella
    Lanza, Marika
    Casili, Giovanna
    Chisari, Giulia
    Munao, Stefania
    Colarossi, Lorenzo
    Cucinotta, Laura
    Campolo, Michela
    Esposito, Emanuela
    Paterniti, Irene
    CELLS, 2022, 11 (04)
  • [10] The antifibrogenic potential of PPARγ ligands in pulmonary fibrosis
    Sime, Patricia J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (02) : 534 - 538
12345